Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.00
-0.21 (-0.99%)
Mar 27, 2026, 11:06 AM EDT - Market open
Arcus Biosciences Employees
Arcus Biosciences had 601 employees as of December 31, 2025. The number of employees decreased by 26 or -4.15% compared to the previous year.
Employees
601
Change (1Y)
-26
Growth (1Y)
-4.15%
Revenue / Employee
$410,982
Profits / Employee
-$587,354
Market Cap
2.63B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 601 | -26 | -4.15% |
| Dec 31, 2024 | 627 | 50 | 8.67% |
| Dec 31, 2023 | 577 | 77 | 15.40% |
| Dec 31, 2022 | 500 | 134 | 36.61% |
| Dec 31, 2021 | 366 | 130 | 55.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Beam Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Viridian Therapeutics | 252 |
| Vera Therapeutics | 249 |
| Catalyst Pharmaceuticals | 182 |
| Disc Medicine | 155 |
RCUS News
- 2 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 24 days ago - Arcus Biosciences: Q4 Beat And Casdatifan's Story So Far - Seeking Alpha
- 4 weeks ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update - Business Wire
- 4 weeks ago - Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer - Business Wire
- 6 weeks ago - Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates - Business Wire
- 2 months ago - Arcus Biosciences, Inc. (RCUS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha